Kovács, E., Bereczky, Z., Kerényi, A., Laczik, R., Nagy, V., Kovács, D., Kovács, S., Pfliegler, G.: Clinical investigation of hereditary and acquired thrombophilic factors in patients with venous and arterial thromboembolism.
Int J Gen Med. 16 5425-5437, 2023.

Bereczki, D., Nagy, B., Kerényi, A., Nagy, G., Szarka, K., Kristóf, K., Szalay, B., Vásárhelyi, B., Bhattoa, H., Kappelmayer, J.: EDTA-Induced Pseudothrombocytopenia Up to 9 Months After Initial COVID-19 Infection Associated with Persistent Anti-SARS-CoV-2 IgM/IgG Seropositivity.
Lab. Med. 53 (2), 206-209, 2022.

Szabó, G., Antal-Szalmás, P., Kerényi, A., Pénzes-Daku, K., Bécsi, B., Kappelmayer, J.: Laboratory Approaches to Test the Function of Antiphospholipid Antibodies.
Semin. Thromb. Hemost. 48 (2), 132-144, 2022.

Gindele, R., Kerényi, A., Kállai, J., Pfliegler, G., Schlammadinger, Á., Szegedi, I., Major, T., Szabó, Z., Bagoly, Z., Kiss, C., Kappelmayer, J., Bereczky, Z.: Resolving Differential Diagnostic Problems in von Willebrand Disease, in Fibrinogen Disorders, in Prekallikrein Deficiency and in Hereditary Hemorrhagic Telangiectasia by Next-Generation Sequencing.
Life (Basel). 11 (3), 1-23, 2021.

Mezei, G., Bekéné Debreceni, I., Kerényi, A., Reményi, G., Szász, R., Illés, Á., Kappelmayer, J., Batár, P.: Dasatinib inhibits coated-platelet generation in patients with chronic myeloid leukemia.
Platelets. 30 (7), 836-843, 2019.

Muszbek, L., Pénzes-Daku, K., Katona, É., Kun, M., Bonnefoy, A., Vezina, Z., Szuber, N., Molnárné Rázsó, K., Bereczky, Z., Kerényi, A., Bécsi, B., Erdődi, F., Rivard, G.: Novel approach to the laboratory diagnosis of antibodies against coagulation factors, with special reference to antifactor XIII antibodies: SE2.4.
Clin. Chem. Lab. Med. 56 (9), 128-129, 2018.

Muszbek, L., Katona, É., Kerényi, A.: Assessment of Factor XIII.
In: Hemostasis and Thrombosis. Eds.: Emmanuel J. Favaloro, Giuseppe Lippi, Humana Press Inc., New York, 277-297, 2017. ISBN: 9781493971947

Kerényi, A., Bekéné Debreceni, I., Oláh, Z., Ilonczai, P., Bereczky, Z., Nagy, B., Muszbek, L., Kappelmayer, J.: Evaluation of flow cytometric HIT assays in relation to an IgG-specific immunoassay and clinical outcome.
Cytom. Part B-Clin. Cytom. 92 (5), 389-397, 2017.

Berkes, A., Szikszay, E., Kappelmayer, J., Kerényi, A., Szabó, T., Újhelyi, L., Bari, K., Balla, G., Balla, J.: Use of Hemadsorption in a Case of Pediatric Toxic Shock Syndrome.
Case Reports in Critical Care. 2017 1-5, 2017.

Póka, R., Damjanovich, P., Károlyi, P., Miszti-Blasius, K., Kerényi, A., Kappelmayer, J.: A firinogénszint referenciaértékei várandósságban.
Magy. Nőorv. Lapok. 79 10-19, 2016.

Bereczky, Z., Speker, M., Gindele, R., Szabó, Z., Oláh, Z., Pfliegler, G., Kerényi, A., Boda, Z.: Diagnostic issues in antithrombin, protein C and protein S deficiency in the hungarian population: experience of a large thrombosis laboratory.
J. Throm. Haemost. 14 (Suppl.), 98, 2016.

Póka, R., Damjanovich, P., Károlyi, P., Miszti-Blasius, K., Kerényi, A., Kappelmayer, J.: Fibrinogen levels in pregnancy have a prognostic role in preeclampsia and in massive obstetric haemorrhage.
Eur. J. Obstet. Gynecol. Reprod. Biol. 206 259, 2016.

Póka, R., Damjanovich, P., Károlyi, P., Miszti-Blasius, K., Kerényi, A., Kappelmayer, J.: Fibrinogen levels in pregnancy have a prognostic role in preeclampsia and in massive obstetric haemorrhage.
Eur. J. Obstet. Gynecol. Reprod. Biol. 206 P259, 2016.

Szűk, T., Fejes, Z., Bekéné Debreceni, I., Kerényi, A., Édes, I., Kappelmayer, J., Nagy, B.: Integrity bare-metal coronary stent-induced platelet and endothelial cell activation results in a higher risk of restenosis compared to Xience everolimus-eluting stents in stable angina patients.
Platelets. 27 (5), 410-419, 2016.

Pénzes-Daku, K., Molnárné Rázsó, K., Katona, É., Kerényi, A., Kun, M., Muszbek, L.: Neutralizing autoantibody against factor XIII A subunit resulted in severe bleeding diathesis with a fatal outcome: characterization of the antibody.
J. Thromb. Haemost. 14 (8), 1517-1520, 2016.

Ilonczai, P., Oláh, Z., Selmeczi, A., Kerényi, A., Bereczky, Z., Póka, R., Schlammadinger, Á., Boda, Z.: Management and outcome of pregnancies in women with antithrombin deficiency: a single-center experience and review of literature.
Blood Coagul. Fibrinolysis. 26 (7), 798-804, 2015.

Árokszállási, A., Kerényi, A., Katona, É., Bereczky, Z., Muszbek, L., Boda, Z., Schlammadinger, Á.: The use of recombinant factor XIII in a major bleeding episode of a patient with congenital factor XIII deficiency - the first experience.
Haemophilia. 21 (1), e118-e121, 2015.

Tóth, J., Lenkey, Á., Oláh, A., Köteles, J., Kissné, S., Kerényi, A., Kappelmayer, J.: Pneumatic tube system for transport of laboratory samples: preanalytical aspects.
Orvosi Hetilap. 155 (28), 1113-1120, 2014.

Kovács, B., Bereczky, Z., Selmeczi, A., Gindele, R., Oláh, Z., Kerényi, A., Boda, Z., Muszbek, L.: Progressive chromogenic anti-factor Xa assay and its use in the classification of antithrombin deficiencies.
Clin. Chem. Lab. Med. 52 (12), 1797-1806, 2014.

Oláh, Z., Szarvas, M., Bereczky, Z., Kerényi, A., Kappelmayer, J., Boda, Z.: Direct thrombin inhibitors and factor Xa inhibitors can influence the diluted prothrombin time used as the initial screen for lupus anticoagulant.
Arch. Pathol. Lab. Med. 137 (7), 967-973, 2013.

Bárdi, E., Jáger, R., Kerényi, A., Schmalcl, E., Schneider, F., Szegedi, I., Kiss, C.: Laboreltérés vagy betegség: APTI idő megnyúlásának hátterében áIIó két eltérés egy beteg esetében.
Hematol. Transzfuziol. 46 (2), 138-140, 2013.

Kovács, B., Bereczky, Z., Oláh, Z., Gindele, R., Kerényi, A., Selmeczi, A., Boda, Z., Muszbek, L.: The Superiority of Anti-FXa Assay Over Anti-FIIa Assay in Detecting Heparin-Binding Site Antithrombin Deficiency.
Am. J. Clin. Pathol. 140 (5), 675-679, 2013.

Benyó, M., Flaskó, T., Molnár, Z., Kerényi, A., Batta, Z., Józsa, T., Hársfalvi, J.: Follow-Up of Thrombin Generation after Prostate Cancer Surgery: Global Test for Increased Hypercoagulability.
PLoS One. 7 (12), e51299, 2012.

Nagy, B., Miszti-Blasius, K., Kerényi, A., Clemetson, K., Kappelmayer, J.: Potential therapeutic targeting of platelet-mediated cellular interactions in atherosclerosis and inflammation.
Curr. Med. Chem. 19 (4), 518-531, 2012.

Oláh, Z., Kerényi, A., Kappelmayer, J., Schlammadinger, Á., Molnárné Rázsó, K., Boda, Z.: Rapid-onset heparin-induced thrombocytopenia without previous heparin exposure.
Platelets. 23 (6), 495-498, 2012.